1. Home
  2. KNSA vs NCLH Comparison

KNSA vs NCLH Comparison

Compare KNSA & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

N/A

Current Price

$95.50

Market Cap

7.7B

Sector

Health Care

ML Signal

N/A

Logo Norwegian Cruise Line Holdings Ltd.

NCLH

Norwegian Cruise Line Holdings Ltd.

N/A

Current Price

$18.13

Market Cap

7.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
KNSA
NCLH
Founded
2015
1966
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
7.1B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
KNSA
NCLH
Price
$95.50
$18.13
Analyst Decision
Strong Buy
Buy
Analyst Count
7
26
Target Price
★ $111.57
$19.67
AVG Volume (30 Days)
869.4K
★ 18.9M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 225.00
N/A
EPS
1.14
★ 1.77
Revenue
$677,564,000.00
★ $5,396,175,000.00
Revenue This Year
$54.80
$2.83
Revenue Next Year
$28.50
$4.87
P/E Ratio
$83.44
★ $9.95
Revenue Growth
★ 60.09
10.71
52 Week Low
$37.02
$13.63
52 Week High
$99.31
$25.13

Technical Indicators

Market Signals
Indicator
KNSA
NCLH
Relative Strength Index (RSI) 58.64 58.59
Support Level $72.76 $18.00
Resistance Level $98.90 $19.11
Average True Range (ATR) 4.32 0.67
MACD -0.24 -0.05
Stochastic Oscillator 68.28 46.98

Price Performance

Historical Comparison
KNSA
NCLH

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 75,000). It operates 35 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet after the pandemic as of May 2022. With 16 passenger vessels on order among its brands through 2037, representing 43,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: